We recently published a list of the Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at ...

Company to host public (L)earnings call on February 28th at 8:30 am ET / 6:30 am MT / 1:30 pm GMTSalt Lake City, UT, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical ...

// Program to find the sum of the sequence of numbers using recursion.

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

The fund will offer $100,000 to $250,000 in capital, as well as a 12 months of lab and office space, to early-stage biotechnology companies that qualified for funding through the federal Small ...